SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS)
IONS 83.39+1.9%10:56 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scott H. Davis who wrote (2609)6/28/1999 9:06:00 PM
From: Mike McFarland  Read Replies (2) of 4676
 
Oh, I don't know about that--it's going to
take awhile just to get through the ibisrna
website. Impossible to value the thing--up til
now I've merely selected a few biotech stocks
which seem to have a lot of potential--and happen
to trade close to book value. I figure that makes
them takeover targets, and perhaps a good value
if they manage to survive on their own as well.
However...this has not paid off this year--so
I'm starting to expand my interests.

Maybe Isis is a terrific bargain here--but
there are always dips, and I don't like that
it's so far from book--negative book no less.
And of course the science will hold me back.
If a person should understand a bit behind the
companies in which he invests, then this one
obviously has more to understand.

Maybe it is just a bit easier to conceptualize
replacement gene therapies, instead of this
anti-gene approach. Maybe I surf some more
through their website I'll have a better idea
how they find their targets, and how they
screen for the darts to hit those targets.

I really should stay away from here til I've
read a whole lot more.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext